company background image
SYNCOMF logo

Syncom Formulations (India) NSEI:SYNCOMF Stock Report

Last Price

₹26.33

Market Cap

₹23.2b

7D

18.6%

1Y

206.2%

Updated

12 Sep, 2024

Data

Company Financials

Syncom Formulations (India) Limited

NSEI:SYNCOMF Stock Report

Market Cap: ₹23.2b

SYNCOMF Stock Overview

Manufactures, markets, and sells pharmaceutical formulation products in India.

SYNCOMF fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance5/6
Financial Health4/6
Dividends0/6

Syncom Formulations (India) Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Syncom Formulations (India)
Historical stock prices
Current Share Price₹26.33
52 Week High₹27.90
52 Week Low₹7.25
Beta1.44
11 Month Change66.96%
3 Month Change109.47%
1 Year Change206.16%
33 Year Changen/a
5 Year Changen/a
Change since IPO225.06%

Recent News & Updates

Syncom Formulations (India) Limited's (NSE:SYNCOMF) 27% Price Boost Is Out Of Tune With Earnings

Aug 30
Syncom Formulations (India) Limited's (NSE:SYNCOMF) 27% Price Boost Is Out Of Tune With Earnings

Recent updates

Syncom Formulations (India) Limited's (NSE:SYNCOMF) 27% Price Boost Is Out Of Tune With Earnings

Aug 30
Syncom Formulations (India) Limited's (NSE:SYNCOMF) 27% Price Boost Is Out Of Tune With Earnings

Syncom Formulations (India) Limited's (NSE:SYNCOMF) 27% Price Boost Is Out Of Tune With Earnings

Jul 16
Syncom Formulations (India) Limited's (NSE:SYNCOMF) 27% Price Boost Is Out Of Tune With Earnings

Some Syncom Formulations (India) Limited (NSE:SYNCOMF) Shareholders Look For Exit As Shares Take 28% Pounding

Mar 21
Some Syncom Formulations (India) Limited (NSE:SYNCOMF) Shareholders Look For Exit As Shares Take 28% Pounding

Syncom Formulations (India) Limited's (NSE:SYNCOMF) 27% Price Boost Is Out Of Tune With Earnings

Dec 29
Syncom Formulations (India) Limited's (NSE:SYNCOMF) 27% Price Boost Is Out Of Tune With Earnings

Syncom Formulations (India) Limited's (NSE:SYNCOMF) Shares Climb 26% But Its Business Is Yet to Catch Up

Dec 27
Syncom Formulations (India) Limited's (NSE:SYNCOMF) Shares Climb 26% But Its Business Is Yet to Catch Up

Shareholder Returns

SYNCOMFIN PharmaceuticalsIN Market
7D18.6%0.7%-1.1%
1Y206.2%58.7%39.7%

Return vs Industry: SYNCOMF exceeded the Indian Pharmaceuticals industry which returned 58.7% over the past year.

Return vs Market: SYNCOMF exceeded the Indian Market which returned 39.7% over the past year.

Price Volatility

Is SYNCOMF's price volatile compared to industry and market?
SYNCOMF volatility
SYNCOMF Average Weekly Movement9.6%
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement6.3%
10% most volatile stocks in IN Market9.5%
10% least volatile stocks in IN Market3.8%

Stable Share Price: SYNCOMF's share price has been volatile over the past 3 months.

Volatility Over Time: SYNCOMF's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Indian stocks.

About the Company

FoundedEmployeesCEOWebsite
1988555Vijay Bankdawww.syncomformulations.com

Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India. It operates through Manufacturing and Dealing in Pharmaceutical Drug & Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, gynae, opthal, ortho, and pediatrics formulations.

Syncom Formulations (India) Limited Fundamentals Summary

How do Syncom Formulations (India)'s earnings and revenue compare to its market cap?
SYNCOMF fundamental statistics
Market cap₹23.17b
Earnings (TTM)₹285.50m
Revenue (TTM)₹2.91b

86.5x

P/E Ratio

8.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SYNCOMF income statement (TTM)
Revenue₹2.91b
Cost of Revenue₹1.76b
Gross Profit₹1.15b
Other Expenses₹864.12m
Earnings₹285.50m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.30
Gross Margin39.53%
Net Profit Margin9.82%
Debt/Equity Ratio25.2%

How did SYNCOMF perform over the long term?

See historical performance and comparison